Trump unveils more prescription drug pricing discounts: 'Major step forward'

The administration has expanded its \"Most Favored Nation\" drug pricing initiative, securing agreements with 26 pharmaceutical companies—representing 90% of the domestic market. By ensuring American patients pay the lowest prices offered globally, the program aims to slash medication costs by up to 80%, with projected total savings for Americans exceeding $600 billion.